1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Autoimmune Drug Focus FEBRUARY 2016

Autoimmune Drug Focus FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Growing Strength Of Roche's Immunology Division Underlined By FY15 Results
Industry Trend Analysis - Janssen Collaboration Secures ViaCyte In Increasingly Competitive Research Arena
Industry Brief - Tresiba Significantly Lowers Hypoglycaemia Than Lantus In Phase IIIb Trial
Industry Brief - Fast Forward Pharmaceuticals Initiates FFP104 Phase II Trials in PBC/CD
Industry Trend Analysis - Cx601 Progressing In Development Race To Corner Blockbuster Market
Industry Trend Analysis - Digital Healthcare Partnerships Offer Expedited Development Potential
Industry Trend Analysis - Breakthrough Designation Affirms Ocrelizumab Blockbuster Potential
Industry Trend Analysis - Pfizer Edges Towards US Biosimilar Infliximab Dominance
Industry Brief - JHL Gains European Rituximab Trial Approval
Industry Brief - Sandoz Acquires Pfizer's Infliximab In EEA
Industry Brief - FDA Approves Pfizer's Xeljanz XR To Treat Moderate-To-Severe RA
Industry Brief - Dosing Begins In Ziarco's ZPL-389 Phase IIa Psoriasis Study
Industry Brief - Promius Pharma Gains Betamethasone Spray Approval
Industry Brief - NICE Recommends Ofev For IPF
Industry Brief - XTL Secures Israeli Patent Covering hCDR1 To Treat Lupus
Industry Trend Analysis - Diversification Key To Overcoming Tecfidera Reliance
Industry Trend Analysis - Generics Remain Essential For Teva As Copaxone Revenues Falter
Industry Brief - Autoimmune Conferences - May 2016

Table Of Contents

Autoimmune Drug Focus FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024

Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global monoclonal antibodies (mAbs) market was valued at USD 85.4 billion in 2015 and is expected to reach a value of USD 138.6 billion by 2024. Increasing R&D pertaining to the development of therapeutic ...

Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2016 Market Research Report

Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Monoclonal Antibody ...

Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • November 2016
  • by Currentpartnering

The Global Antibody Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.